The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
LC3-associated phagocytosis protects against inflammation and liver fibrosis via immunoreceptor inhibitory signaling
Abstract
LC3-associated phagocytosis is a protective mechanism against inflammation, with antifibrogenic properties in the liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“activation of a noncanonical form of autophagy (LC3-associated phagocytosis) shifts the macrophage phenotype toward an anti-inflammatory stage with resulting antifibrogenic effects (133, 134)”
From Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy (2024) · doi:10.1146/annurev-pharmtox-020524-012013 · cites this paper as [134]
Citations
Cites
2 retracted
Martinez, J., Malireddi, R. K. S., Lu, Q., Cunha, L. D., Pelletier, S., Gingras, S., Orchard, R., Guan, J.-L., Tan, H., Peng, J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3192 · Cited by 758 · cited 2×
“Rubicon is also a positive regulator of the phagocytic reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) complex, both by binding and stabilizing the phagocytic oxidase p22phox and by promoting assembly of the NOX2 complex (6, 7, 9, 10).”
BackgroundRetractedMartinez, J., Cunha, L. D., Park, S., Yang, M., Lu, Q., Orchard, R., Li, Q.-Z., Yan, M., Janke, L., Guy, C., et al. (2016) · Nature · doi:10.1038/nature17950 · Cited by 381 · cited 1×
“Last, the beneficial role of LAP in other human inflammatory disorders also merits further investigation, in light of our results in patients with cirrhosis, and those reported in mice for lupus erythematosus (40).”
ResultRetractedAMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424 · cited 2×
“Sustained hepatic inflammation originating from monocytes/macrophages is crucial for progression of chronic liver diseases (1, 3).”
BackgroundToll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis
Sanjuan, M. A., Dillon, C. P., Tait, S. W. G., Moshiach, S., Dorsey, F., Connell, S., Komatsu, M., Tanaka, K., Cleveland, J. L., Withoff, S., et al. (2007) · Nature · doi:10.1038/nature06421 · Cited by 1,347 · cited 1×
“In contrast to autophagy, LAP proceeds independently of the preinitiation AMP-activated protein kinase–mammalian target of rapamycin–Unc-51 like autophagy activating kinase (AMPK/mTOR/ULK1) auto phagy activating kinase (ULK1) autophagy complex but nevertheless requires some autophagic components, such as the class III…”
BackgroundMatsunaga, K., Saitoh, T., Tabata, K., Omori, H., Satoh, T., Kurotori, N., Maejima, I., Shirahama-Noda, K., Ichimura, T., Isobe, T., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1846 · Cited by 1,235
Petiot, A., Ogier-Denis, E., Blommaart, E. F. C., Meijer, A. J., & Codogno, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.992 · Cited by 1,164
Self-citationZhong, Y., Wang, Q. J., Li, X., Yan, Y., Backer, J. M., Chait, B. T., Heintz, N., & Yue, Z. (2009) · Nature Cell Biology · doi:10.1038/ncb1854 · Cited by 1,005
Properties of mouse and human IgG receptors and their contribution to disease models
Bruhns, P. (2012) · Blood · doi:10.1182/blood-2012-01-380121 · Cited by 847 · cited 1×
“It is likely that this protection is mediated by endogenous mouse IgG binding to human FcRIIA, as it has been previously shown that all subclasses of mouse IgG can bind to human FcRIIA (36) and that mice with chronic liver injury, including chronic CCl4 administration, display hyperimmunoglobulinemia (37).”
BackgroundCB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis
Teixeira-Clerc, F., Julien, B., Grenard, P., Van Nhieu, J. T., Deveaux, V., Li, L., Serriere-Lanneau, V., Ledent, C., Mallat, A., & Lotersztajn, S. (2006) · Nature Medicine · doi:10.1038/nm1421 · Cited by 528
Self-citationAutophagy in liver diseases: Time for translation?
Allaire, M., Rautou, P.-E., Codogno, P., & Lotersztajn, S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.026 · Cited by 378
Self-citationTanaka, S., Hikita, H., Tatsumi, T., Sakamori, R., Nozaki, Y., Sakane, S., Shiode, Y., Nakabori, T., Saito, Y., Hiramatsu, N., et al. (2016) · Hepatology · doi:10.1002/hep.28820 · Cited by 376 · cited 7×
“Rubiconflox/floxLysM-Cre−/− littermates were used as controls.”
BackgroundMethodInfluentialHepatic fibrosis: molecular mechanisms and drug targets
Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., & Mallat, A. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095906 · Cited by 325 · cited 3×
“INTRODUCTION Chronic liver injury develops in response to alcohol, nonalcoholic steatohepatitis (NASH), or viral hepatitis, and exposes to fibrosis and end-stage cirrhosis (1, 2).”
BackgroundSelf-citationp62/SQSTM1 – steering the cell through health and disease
Sánchez-Martín, P., & Komatsu, M. (2018) · Journal of Cell Science · doi:10.1242/jcs.222836 · Cited by 282 · cited 1×
“In contrast, the amount of the autophagy cargo protein p62 (20) did not vary between PBMCs from both groups (fig.”
BackgroundLC3-Associated Phagocytosis and Inflammation
Heckmann, B. L., Boada-Romero, E., Cunha, L. D., Magne, J., & Green, D. R. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.08.012 · Cited by 276
Macrophage autophagy protects against liver fibrosis in mice
Lodder, J., Denaës, T., Chobert, M.-N., Wan, J., El-Benna, J., Pawlotsky, J.-M., Lotersztajn, S., & Teixeira-Clerc, F. (2015) · Autophagy · doi:10.1080/15548627.2015.1058473 · Cited by 266
Self-citationMucosal-associated invariant T cells are a profibrogenic immune cell population in the liver
Hegde, P., Weiss, E., Paradis, V., Wan, J., Mabire, M., Sukriti, S., Rautou, P.-E., Albuquerque, M., Picq, O., Gupta, A. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04450-y · Cited by 232 · cited 1×
“Moreover, mice deficient for LAP in myeloid cells showed pronounced hepatic inflammatory cell infiltration and cytokine production in response to chronic liver injury, a step required for the development and progression of liver fibrosis (2, 3, 17, 34, 35).”
BackgroundSelf-citationV-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation
Florey, O., Gammoh, N., Kim, S. E., Jiang, X., & Overholtzer, M. (2015) · Autophagy · doi:10.4161/15548627.2014.984277 · Cited by 220
Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis
Mallat, A., & Lotersztajn, S. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00230.2013 · Cited by 211
Self-citationFc receptors are major mediators of antibody based inflammation in autoimmunity
Hogarth, P. M. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(02)00409-0 · Cited by 189 · cited 17×
“Moreover, the increased expression of FCGR2A/FcRIIA in blood monocytes from patients with cirrhosis, associated with an increase in IgG complexes engulfment, suggests that IgG-FcRIIA signaling is a likely candidate for LAP activation.”
BackgroundInfluentialAutophagy: A Druggable Process
Morel, E., Mehrpour, M., Botti, J., Dupont, N., Hamaï, A., Nascimbeni, A. C., & Codogno, P. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104936 · Cited by 168
Self-citationYang, C.-S., Lee, J.-S., Rodgers, M., Min, C.-K., Lee, J.-Y., Kim, H. J., Lee, K.-H., Kim, C.-J., Oh, B., Zandi, E., et al. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.018 · Cited by 164
Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?
Nagelkerke, S. Q., & Kuijpers, T. W. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00674 · Cited by 161
Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis
Dahdah, A., Gautier, G., Attout, T., FIORE, F., Lebourdais, E., Msallam, R., Daëron, M., Monteiro, R. C., Benhamou, M., Charles, N., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75212 · Cited by 158
Self-citationSERUM IMMUNE COMPLEXES AND DISEASE ACTIVITY IN LUPUS NEPHRITIS
Levinsky, R. J., Cameron, J. S., & Soothill, J. F. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91998-5 · Cited by 156
Mkaddem, S. B., Murua, A., Flament, H., Beauport, D. T., Bounaix, C., Danelli, L., Launay, P., Benhamou, M., Blank, U., Daugas, É., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00294-0 · Cited by 120
Self-citationThe Acute-on-Chronic Liver Failure Syndrome, or When the Innate Immune System Goes Astray
Clària, J., Arroyo, V., & Moreau, R. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600818 · Cited by 112 · cited 20×
“Our data showed that activation of LAP observed in blood monocytes from patients with cirrhosis is lost in patients progressing to ACLF.”
BackgroundInfluentialSelf-citationDenaës, T., Lodder, J., Chobert, M.-N., Ruiz, I., Pawlotsky, J., Lotersztajn, S., & Teixeira-Clerc, F. (2016) · Scientific Reports · doi:10.1038/srep28806 · Cited by 105 · cited 1×
“We have shown that mice lacking Atg5 in myeloid cells are more susceptible to liver inflammation and fibrosis when exposed to chronic toxic injury (16, 17).”
BackgroundSelf-citationShifting FcγRIIA-ITAM from activation to inhibitory configuration ameliorates arthritis
Mkaddem, S. B., Hayem, G., Jönsson, F., Rossato, E., Boedec, E., Boussetta, T., Benna, J. E., Launay, P., Goujon, J., Benhamou, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74572 · Cited by 97 · cited 9×
“FcRIIA has double-edged sword functions, with anti- and proinflammatory properties depending on specific core signaling pathways (25, 26).”
BackgroundInfluentialSelf-citationDectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways
Seifert, L., Deutsch, M., Alothman, S., Alqunaibit, D., Werba, G., Pansari, M., Pergamo, M., Ochi, A., Torres-Hernandez, A., Levie, E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.058 · Cited by 97 · cited 1×
“In this context, Dectin is of particular interest, since it displays anti-inflammatory and antifibrogenic properties in the liver (39).”
BackgroundIgG1 and IVIg induce inhibitory ITAM signaling through FcγRIII controlling inflammatory responses
Aloulou, M., Mkaddem, S. B., Biarnes‐Pelicot, M., Boussetta, T., Souchet, H., Rossato, E., Benhamou, M., Crestani, B., Zhu, Z., Blank, U., et al. (2012) · Blood · doi:10.1182/blood-2011-08-376046 · Cited by 92 · cited 2×
“In contrast, upon interaction with uncomplexed IgG (either in monomeric or dimeric forms) or with specific antibody F(ab′)2 fragments, the receptor generates ITAMi-dependent signals (30) with antiinflammatory effects, after stable recruitment and activation of the phosphatase SHP-1 (25, 26).”
BackgroundSelf-citationAutophagy in chronic liver diseases: the two faces of Janus
Gual, P., Gilgenkrantz, H., & Lotersztajn, S. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00295.2016 · Cited by 91
Self-citationInhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
Habib, A., Chokr, D., Wan, J., Hegde, P., Mabire, M., Siebert, M., Ribeiro-Parenti, L., Le Gall, M., Lettéron, P., Pilard, N., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316137 · Cited by 91
Self-citationGandoura, S., Weiss, E., Rautou, P., Fasseu, M., Gustot, T., Lemoine, F., Hurtado-Nédelec, M., Hego, C., Vadrot, N., Elkrief, L., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.025 · Cited by 81 · cited 21×
“Our data showed that activation of LAP observed in blood monocytes from patients with cirrhosis is lost in patients progressing to ACLF.”
BackgroundMethodInfluentialSelf-citationImportance of Connexin-43 based gap junction in cirrhosis and acute-on-chronic liver failure
Vairappan, B., Dhar, D. K., Warner, A. E., Li, W.-Y. V., Amiri, A., Bright, B., Mookerjee, R. P., Davies, N. A., Becker, D. L., & Jalan, R. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.023 · Cited by 73
A ravenous defense: canonical and non-canonical autophagy in immunity
Sil, P., Muse, G. W., & Martinez, J. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.10.004 · Cited by 69 · cited 6×
“Rubicon is also a positive regulator of the phagocytic reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 (NOX2) complex, both by binding and stabilizing the phagocytic oxidase p22phox and by promoting assembly of the NOX2 complex (6, 7, 9, 10).”
BackgroundInfluentialSerum Gamma-globulins in Acute and Chronic Liver Diseases
Tomasi, T. B., & Tisdale, W. A. (1964) · Nature · doi:10.1038/201834a0 · Cited by 66 · cited 2×
“It is known for decades that patients with chronic liver diseases show hyperimmunoglobulinemia (24), but the Fig.”
BackgroundWALKER, B. A. M., Hagenlocker, B. E., Stubbs, E. B., Sandborg, R. R., Agranoff, B. W., & Ward, P. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.2.735 · Cited by 58
Association of FcγRIIa (CD32a) with Lipid Rafts Regulates Ligand Binding Activity
Bournazos, S., Hart, S. P., Chamberlain, L. H., Glennie, M. J., & Dransfield, I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900107 · Cited by 52
Barabé, F., Rollet, E., Gilbert, C., Fernandes, M. J., Naccache, S. N., & Naccache, P. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.4042 · Cited by 32
Liu, W. T., Jing, Y., Han, Z. P., Li, X. N., Liu, Y., Lai, F. B., Li, R., Zhao, Q., Wu, M., & Wei, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122739 · Cited by 28 · cited 1×
“It is likely that this protection is mediated by endogenous mouse IgG binding to human FcRIIA, as it has been previously shown that all subclasses of mouse IgG can bind to human FcRIIA (36) and that mice with chronic liver injury, including chronic CCl4 administration, display hyperimmunoglobulinemia (37).”
BackgroundThe Protein Tyrosine Phosphatase SHP-1 Regulates Phagolysosome Biogenesis
Gómez, C. P., Shio, M. T., Duplay, P., Olivier, M., & Descoteaux, A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103021 · Cited by 26 · cited 1×
“In addition, our data are in line with previous reports showing that SHP-1 associates with phagosomes and promotes their biogenesis (38).”
ResultAn improved flow cytometry assay to monitor phagosome acidification
Colas, C., Menezes, S., Gutiérrez-Martínez, E., Péan, C. B., Dionne, M., & Guermonprez, P. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.06.008 · Cited by 24
Peptide inhibition of p22phox and Rubicon interaction as a therapeutic strategy for septic shock
Kim, Y.-R., Koh, H.-J., Kim, J., Yun, J.-S., Jang, K., Lee, J., Jung, J. U., & Yang, C. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.046 · Cited by 23
A model of acute kidney injury in mice with cirrhosis and infection
Carl, D. E., Ghosh, S. S., Gehr, T. W. B., Abbate, A., Toldo, S. A., & Sanyal, A. J. (2015) · Liver International · doi:10.1111/liv.13023 · Cited by 18
Cited by
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Self-citationAutophagy in inflammation, infection, and immunometabolism
Deretic, V. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.018 · Cited by 862
“, 2020) and antiinflammatory and anti-fiibrogenic activity in monocytes responding to liver injury (Wan et al., 2020).”
BackgroundWen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695
Machinery, regulation and pathophysiological implications of autophagosome maturation
Zhao, Y. G., Codogno, P., & Zhang, H. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00392-4 · Cited by 572
Self-citationMetabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Metadata
- Authors
- Wan, J., Weiss, E., Ben Mkaddem, S., Mabire, M., Choinier, P.-M., Picq, O., Thibault-Sogorb, T., Hegde, P., Pishvaie, D., Bens, M., Broer, L., Gilgenkrantz, H., Moreau, R., Saveanu, L., Codogno, P., Monteiro, R. C., & Lotersztajn, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Université de Paris, Centre de Recherche sur l'Inflammation (CRI), INSERM, U1149, CNRS, ERL 8252, F-75018 Paris, France.
- Hôpital Beaujon (FR)
- Corresponding author
- Wan, JingHong
- Weiss, Emmanuel
- Saveanu, Loredana
- Codogno, Patrice
- Monteiro, Renato C.
- Lotersztajn, Sophie
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2020-04-15
- Volume
- 12
- Issue
- 539
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3017134069
- Cited by
- 77
- References
- 45
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 10 · 2023: 13 · 2022: 17 · 2021: 18 · 2020: 6
- FWCI
- 9.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-18-CE14-0006)
- Fondation pour la Recherche Médicale (DEQ20150331726)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- LC3-associated phagocytosis, liver fibrosis, inflammation, Itami City, LAP, intravenous immunoglobulin, chronic liver disease, autophagy
- MeSH terms
- Animals, Humans, Inflammation, Liver Cirrhosis, Mice, Inbred C57BL, Microtubule-Associated Proteins, Phagocytosis, Signal Transduction, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.